A nonfucosylated human antibody to CD19 with potent B-cell depletive activity for therapy of B-cell malignancies
Pina M. Cardarelli(Medway School of Pharmacy), David J. King(AnaBios (United States)), Jie Liu, Michelle Kuhne, Amie Pham, Alison Witte, Maria-Cristina Moldovan-Loomis, David Passmore, Ben Preston, Chin Pan, Haichun Huang, Chetana Rao‐Naik, Diann Blanset(Boehringer Ingelheim (France)), Sharline Chen
Cited by 47
Related Papers
High-Level Expression of a Recombinant Antibody from Myeloma Cells Using a Glutamine Synthetase Gene as an Amplifiable Selectable Marker
|Nature Biotechnology|1992|465
A single amino acid substitution abolishes the heterogeneity of chimeric mouse/human (IgG4) antibody
|Molecular Immunology|1993|243
Comparative metabolism and retention of iodine-125, yttrium-90, and indium-111 radioimmunoconjugates by cancer cells.
|PubMed|1996|212
Multimerization behaviour of single chain Fv variants for the tumour-binding antibody B72.3
|Protein Engineering Design and Selection|1994|122